{
    "Trade/Device Name(s)": [
        "Elecsys SHBG Immunoassay System",
        "Elecsys SHBG",
        "SHBG test"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K102814",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031717"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "December 15, 2010",
    "Summary Letter Received Date": "December 16, 2010",
    "Submission Date": "September 23, 2010",
    "Regulation Number(s)": [
        "21CFR862.1680"
    ],
    "Regulation Name(s)": [
        "Radioimmunoassay, testosterone and dihydrotestosterone"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Sex hormone-binding globulin (SHBG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "cobas e 411",
        "MODULAR ANALYTICS E170",
        "cobas e 601"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Elecsys SHBG electrochemiluminescent immunoassay for quantitative determination of SHBG in serum and plasma",
    "Indications for Use Summary": "Immunoassay for in vitro quantitative determination of sex hormone-binding globulin in human serum and plasma as an aid in the diagnosis of androgen disorders, intended for use on Elecsys and cobas e immunoassay analyzers",
    "fda_folder": "Clinical Chemistry"
}